Q BioMed wins Strontium89 supply deal for DOD, VA
March 2, 2021 -- Biotech company Q BioMed has landed a contract to supply its Strontium89 metastatic bone cancer palliation radiopharmaceutical to the U.S. Department of Defense (DOD) and the Department of Veterans Affairs (VA). Read More
ASTRO lauds Biden's CMS administrator nomination
March 1, 2021 -- The American Society for Radiation Oncology (ASTRO) is lauding the Biden administration's nomination of Chiquita Brooks-LaSure as head of the U.S. Centers for Medicare and Medicaid Services (CMS). Read More
U.K.'s NICE recommends Sirtex's microsphere for liver cancer
February 26, 2021 -- The U.K. National Institute for Health and Care Excellence (NICE) gave radiation oncology firm Sirtex Medical positive guidance on the use of its selection internal radiation therapy with SIR-Spheres yttrium-90 microspheres for the treatment of adults with unresectable advanced hepatocellular carcinoma. Read More
C-RAD deploys radiation oncology system in Mass.
February 22, 2021 -- Swedish radiation therapy developer C-RAD has announced an installation at Alliance Radiation Oncology of Newburyport, Massachusetts. Read More
European Commission gives OK to big Siemens/Varian deal
February 19, 2021 -- The European Commission (EC) has given its blessing to the bid by Siemens Healthineers to acquire radiation oncology firm Varian Medical Systems. The EC approved the deal after Siemens gave assurances that it would keep its systems open to third parties. Read More
Theragnostics, German hospital to study THG-008 for PET
February 17, 2021 -- Theragnostics and Essen University Hospital in Germany will study the investigational agent THG-008 for use in PET imaging of a range of cancers. Read More
Radionuclide therapy, immunotherapy can slow prostate cancer
February 9, 2021 -- Pairing radionuclide therapy with immunotherapy can successfully slow prostate cancer progression and increases survival time, according to new research published in the February edition of the Journal of Nuclear Medicine. Read More
Hologic touts BioZorb breast tissue marker
February 4, 2021 -- Hologic is highlighting a study that found its BioZorb 3D tissue marker to be a safe adjunct to breast-conserving surgery and radiation therapy in patients with breast cancer. Read More
Aikido invests in prostate radiopharma firm
February 2, 2021 -- Aikido Pharma has made an investment in Convergent Therapeutics, a company developing a radiopharmaceutical for treating prostate cancer. Aikido made the investment in the form of a $2 million convertible promissory note purchase agreement. Read More
How higher radiation stacks up when treating lung cancer
February 1, 2021 -- Two studies presented at the International Association for the Study of Lung Cancer world conference look at the use of higher radiation boost doses for lung cancer. Read More
Special Feature
IMV: Imaging boosts precision in radiation therapy

Radiation therapy is a relatively stable market, with procedure volume growing at an average annual rate of 2%. But major technological changes in radiation oncology are brewing under the surface, according to a new report by IMV Medical Information Division. Read more